Pipilis Athanasios Cardiologist ClinicalDirector, 1st Cardiology Department HYGEIA Hospital
Education & Academic Qualifications
- Medical School, University of Athens (1982)
- Specialty in cardiology (1989)
MD thesis, University of Athens (1992), The use of captopril and of isosorbide mononitrate in the acute phase of myocardial infarction
Fellowship in Societies, Membership in Journal Editorial Committees
Member of Hellenic Cardiology Society (HCS)
Member of the Board of HCS (1999-2001 and 2003-2005)
Special Secretary of the Board of HSC (2001-2003)
Fellow of European Society of Cardiology
Fellow of American College of Cardiology
Chairman of Working Group of Clinical Epidemiology and Prevention of HSC (2002-2004)
Member of the Working group of Invasive Cardiology of HSC
Member of the Working group of Clinical Epidemiology and Prevention of HSC
Member of Hellenic Society of Atherosclerosis
Member of the Board of the Hellenic Society of Cardiovascular Health
Member of Institute for the Study of Thrombosis and Antithrombotic treatment
Reviewer of Hellenic Journal of Cardiology
Reviewer of International Journal of Cardiology
SHO and Registrar, Cardiac dept, Guy’s Hospital London (1986-1989)
Research registrar, Honorary lecturer and senior registrar, John Radcliffe Hospital, Oxford (1989-1992)
Senior registrar, Cardiology dept, Hygeia Hospital (1992-1999)
Deputy Director, Cardiology dept, Hygeia Hospital (1999-2011)
Director, Cardiology dept, Hygeia Hospital (2011-to date)
Honorary lecturer, John Radcliffe Hospital, Oxford (1991-1992)
Participation in the yearly teaching sessions of post graduate training of the Cardiology Clinic of University of Athens
Clinical & Research Interest
Acute coronary syndromes
Antithrombotic treatment in Atrial fibrillation, Acute coronary syndromes
Treatments of Acute myocardial infarction (fibrinolysis, antithrombins, antiplatelet therapy)
National Registries on atrial fibrillation and Acute myocardial infarction
Antithrombotic treatment in Atrial fibrillation
Risk prediction charts in primary prevention (National adaptation of HeartScore)
Pipilis A, Makrygiannis S, Chrisanthopoulou E, Sourlas N, Kaliambakos S, Ntailianas P. Gastrointestinal bleeding in patients receiving antiplatelet and anticoagulant therapy: practical guidance for restarting therapy and avoiding recurrences. Hellenic J Cardiol. 2014 Nov-Dec;55(6):499-509. PubMed PMID:25432202.
Pipilis A, Farmakis D, Kaliambakos S, Antoniou A, Goudevenos J, Lekakis J; RAFTING Investigators. Anticoagulant therapy is prescribed less often in paroxysmal atrial fibrillation regardless of thromboembolic risk: results from the Registry of Atrial Fibrillation To Investigate New Guidelines (RAFTING). Int J Cardiol. 2014 Aug 20;175(3):569-70. Doi 10.1016/j.ijcard.2014.05.032. Epub 2014 May 17. PubMed PMID: 24874899.
Farmakis D, Pipilis A, Antoniou A, et al. Clinical profile and therapeutic management of patients with atrial fibrillation in Greece: results from the Registry of Atrial Fibrillation to Investigate New Guidelines (RAFTING). Hellenic J Cardiol. 2013 Sep-Oct;54(5):368-75. PubMed PMID: 24100180.
Pipilis A, Andrikopoulos G, Lekakis J, et al. HELIOS Group. Do we reperfuse those in most need? Clinical characteristics of ST-elevation myocardial infarction patients receiving reperfusion therapy in the countrywide registry HELIOS. Hellenic J Cardiol. 2010 Nov-Dec;51(6):486-91. PubMed PMID: 21169180.
Pipilis A, Lazaros G, Tsakonas G, Stefanadis C. Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stenting. Hellenic J Cardiol. 2010 Jul-Aug;51(4):330-7. Review. PubMed PMID: 20650831.